
Libvatrep (SAF312) is a мощный, селективный non-competitive ингибитор/антагонист of the transient рецептор potential cation channel subfamily V member 1 (TRPV1), shows potential for treatment of ocular surface pain.
Libvatrep (SAF312) is a potent, selective non-competitive inhibitor/antagonist of the transient receptor potential cation channel subfamily V member 1 (TRPV1), shows potential for treatment of ocular surface pain.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.